Navigation Links
Molecular Diagnostics - Global Strategic Business Report
Date:11/25/2013

DUBLIN, November 25, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/wgq58t/molecular) has announced the addition of the "Molecular Diagnostics - Global Strategic Business Report" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)


This report analyzes the worldwide markets for Molecular Diagnostics in US$ million by the following Product Segments: Infectious Disease Testing, Pharmacogenomics, and Cancer Screening. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets.

The report profiles 103 companies including many key and niche players such as Abbott Laboratories, Abbott Molecular, Life Technologies Corporation, Celera, Biomérieux, CytoCore Inc., ELITech Group, GE Healthcare, Genzyme Corporation, Hologic, Inc., Laboratory Corporation of America® Holdings, MiraiBio, Inc., Novartis Diagnostics, QIAGEN N. V, Quest Diagnostics, Inc., Roche Diagnostics, Siemens Healthcare Diagnostics, and Tecan Group Ltd. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.


Key Topics Covered:


I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

2. A REVIEW OF MEDICAL DIAGNOSTICS MARKET

3. COMPETITIVE DYNAMICS IN THE MOLECULAR DIAGNOSTICS MARKET

4. MARKET TRENDS & ISSUES

5. PRODUCT & TECHNOLOGY OVERVIEW

6. AN INSIGHT INTO APPLICATIONS OF MOLECULAR DIAGNOSTICS

7. RECENT INDUSTRY ACTIVITY

8. INDUSTRY ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER

9. PRODUCT DEVELOPMENTS/ INTRODUCTIONS

10. PRODUCT LAUNCHES IN RECENT PAST - A PERSPECTIVE BUILDER

11. FOCUS ON SELECT GLOBAL PLAYERS

12. GLOBAL MARKET PERSPECTIVE

III. MARKET

1. THE UNITED STATES

2. CANADA

3. JAPAN

4. EUROPE

4a. FRANCE

4b. GERMANY

4c. ITALY

4d. THE UNITED KINGDOM

4e. REST OF EUROPE

5. ASIA-PACIFIC

6. REST OF WORLD

IV. COMPETITIVE LANDSCAPE

Companies Mentioned

- Abbott Laboratories (USA)
- BD Biosciences (USA)
- bioTheranostics, Inc. (USA)
- Cepheid, Inc. (USA)
- DaAn Gene Co., Ltd. (China)
- Danaher Corporation (USA)
- DermTech International (USA)
- Diagenode SA (Belgium)
- GE Healthcare (UK)
- GeneNews Ltd. (Canada)
- Genomic Health, Inc. (USA)
- Genzyme Corporation (USA)
- Health Discovery Corporation (USA)
- Illumina, Inc. (USA)
- Immucor, Inc. (USA)
- Incelldx, Inc. (USA)
- Ipsogen SA (France)
- Ipsos Healthcare (France)
- Orchid Cellmark, Inc. (USA)
- Life Technologies Corporation (USA)
- Novartis Diagnostics (USA)
- Orion Genomics (USA)
- Qiagen NV (The Netherlands)
- Quattromed Ltd. (Estonia)
- Quest Diagnostics, Inc. (USA)
- Roche Molecular Diagnostics (USA)
- Trovagene, Inc. (USA)
- Tyrian Diagnostics Ltd. (Australia)
- Vascular Biosciences (USA)
- Vermillion, Inc. (USA)


For more information visit http://www.researchandmarkets.com/research/wgq58t/molecular

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Biomedical Research Foundation (BRF) Recruits Two Eminent Scientists --Pradeep Garg, Ph.D., And Sudha Garg, Ph.D. -- To Run Newly-Created Louisiana Center For Molecular Imaging And Therapy
2. 2014 Analysis of the European Molecular Diagnostics Market: Segment Forecasts and Supplier Shares
3. Caris Life Sciences Presents Key Biomarker Data at 2013 Association for Molecular Pathology (AMP) Annual Meeting
4. Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis
5. Hun School Bio Students Conduct Original Molecular Research in Conjunction with Rutgers University
6. Molecular Genetics Research to Fuel Growth in the qPCR and dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc.
7. This week in Molecular Biology and Evolution: A step ahead of influenza, honeybee sex
8. EU sponsors fabrication of molecular electronic components on the sub-nanometer scale
9. Personal Genome Diagnostics and MolecularMD Collaborate to Provide Advanced Genomic Testing Services to Cancer Drug Developers
10. This week in Molecular Biology and Evolution
11. Molecular Diagnostics in Genetic Testing - 2013 Study Analyzes the Size and Growth of the Molecular Diagnostics in Genetic Testing Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created ... services and solutions to the healthcare market. The company's primary focus is on ... sales and marketing strategies that are necessary to help companies efficiently bring their ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
Breaking Biology Technology:
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
Breaking Biology News(10 mins):